phase 2 trial of chinese covid-19 vaccine

Beijing: A phase 2 trial of a Covid-19 vaccine candidate conducted in China has found that the vaccine is safe and induces an immune response, according to a new study published in the journal The Lancet. This comes barely 24 hours after…